成人抑郁症患者的临床特征描述:面向个体化管理
本文系统描述了个体化抑郁症治疗需考虑的显著域,总结了各域现有研究证据并回顾相关评估工具,特别关注其在常规临床实践中的适用性。文中指出个体化治疗研究证据尚零散,但部分二次分析提示某些变量可能有助于识别对不同抗抑郁药或药物与特定心理治疗反应不同的患者,并强调了研究需解决的主要未满足需求。
要点
- 个体化治疗研究证据尚零散,治疗选择常基于偏好与安全性以试错方式进行。
- 部分二次分析提示某些变量可能识别对不同抗抑郁药或治疗方式反应不同的患者。
- 现代抑郁症管理日趋复杂,神经认知与躯体共病等域部分已可可靠个体化。
核心结论
- 个体化抑郁症治疗的研究证据目前尚零散,但部分变量可能有助于识别治疗反应不同的患者。
- 需要开展大规模观察性研究并使用全面的自评与临床测量工具来开发决策支持工具。
研究设计与样本
- 本文为综述,系统描述个体化抑郁症治疗应考虑的显著域并总结各域研究证据。
- 文中回顾各域相关评估工具,特别关注其在常规临床实践中的适用性及纳入全面测量组合的可能性。
主要发现
- 多数抑郁症患者首次治疗未达缓解,治疗选择常基于医患偏好与安全性以试错方式进行。
- 临床试验数据库的个体患者数据荟萃分析与机器学习等二次分析提示某些变量可能识别治疗反应差异。
- 神经认知与躯体共病等域的部分成分已可可靠个体化。
临床怎么用
- 临床应系统评估个体化治疗需考虑的多个显著域,而非仅选择抗抑郁药和/或心理治疗。
- 文中在证据允许处提供了可立即用于使抑郁症管理更个体化的具体建议。
局限性
- 指导个体化的研究证据目前尚零散。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Depression is widely acknowledged to be a heterogeneous entity, and the need to further characterize the individual patient who has received this diagnosis in order to personalize the management plan has been repeatedly emphasized. However, the research evidence that should guide this personalization is at present fragmentary, and the selection of treatment is usually based on the clinician's and/or the patient's preference and on safety issues, in a trial-and-error fashion, paying little attention to the particular features of the specific case. This may be one of the reasons why the majority of patients with a diagnosis of depression do not achieve remission with the first treatment they receive. The predominant pessimism about the actual feasibility of the personalization of treatment of depression in routine clinical practice has recently been tempered by some secondary analyses of databases from clinical trials, using approaches such as individual patient data meta-analysis and machine learning, which indicate that some variables may indeed contribute to the identification of patients who are likely to respond differently to various antidepressant drugs or to antidepressant medication vs. specific psychotherapies. The need to develop decision support tools guiding the personalization of treatment of depression has been recently reaffirmed, and the point made that these tools should be developed through large observational studies using a comprehensive battery of self-report and clinical measures. The present paper aims to describe systematically the salient domains that should be considered in this effort to personalize depression treatment. For each domain, the available research evidence is summarized, and the relevant assessment instruments are reviewed, with special attention to their suitability for use in routine clinical practice, also in view of their possible inclusion in the above-mentioned comprehensive battery of measures. The main unmet needs that research should address in this area are emphasized. Where the available evidence allows providing the clinician with specific advice that can already be used today to make the management of depression more personalized, this advice is highlighted. Indeed, some sections of the paper, such as those on neurocognition and on physical comorbidities, indicate that the modern management of depression is becoming increasingly complex, with several components other than simply the choice of an antidepressant and/or a psychotherapy, some of which can already be reliably personalized.
引用
- Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020. PMID: 32931110. doi:10.1002/wps.20771
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。